Biocytogen’s Post

Join me for an insightful panel discussion at the BIO International Convention in San Diego on June 5. Our session, "Evolution of the IRA: A New-Year, a Potential New Administration, Yet Tackling the Same Access and Affordability Challenges," will feature expert panelists like William Roth, Gerry Gleeson, Albert Thigpen, and William Sarraille. They will demystify how IRA will change the landscape for emerging pharmaceutical companies and put recent developments in plain language. Don't miss out on this opportunity to stay ahead of the curve in the ever-changing world of drug pricing and Medicare negotiation. #BIO2024 #IRA #drugpricing #medicarenegotiation

What better way to celebrate #OpenScienceWeek than by registering for our CACHE 2 Participant Spotlight webinar! But you'll have to be quick because it's tomorrow, Wednesday September 18 at 1pm EDT. The two featured teams used very different methods, including using AI and citizen science, to make top-scoring predictions of what small molecules bind to the RNA-binding site on the NSP13 helicase of the COVID virus. This site is highly conserved, so an antiviral developed from these molecules could be a powerful tool against all coronaviruses. Those predictions, and the experimental data validating them as hits, are all shared openly because we want to empower everyone to be prepared for any future pandemics. Find out more, and the registration link, in the post below. Hope to see you there!

The Fruit of Knowledge is a current project that coincidently has come ten years after contributing to the early online success of cannabis businesses after legalization in Colorado. I was working with the Weed Life Network and was part of an SEO team that came up with 'Dispensary' as the keyword search term that was recognized as code for recreational marijuana ~ LOL. As they say, we've come a long way, baby! At least with the emerging psychedelic industry, we can use actual names and correct terms to share information online. Hat tip to all of my connects from those early days of path-finding and trail-blazing. *In 2024, the global cannabis market is projected to reach nearly $40 billion in gross revenue. It's important to note that this figure includes both legal and illegal cannabis markets. The legal market is growing rapidly as more countries and states legalize cannabis for medical and recreational use.

▪ It was great to catch up with old friends and colleagues, seeing them now in these positions of influence, hugely successful careers, taking ownership, protecting our two-legged and four-legged public. ▪ It was great to connect with FDA in this relaxed setting - instead of during an inspection or regulatory meeting! 😉 ▪ It was also great to meet folks for the first time! The networking opportunities were great, though I did miss quite a few of you! A few take-aways: 🔹 Basic, fundamental GMP issues continue to be seen by FDA across the industry, despite the tools, technology, resources, policy, guidance documents, history of observations, warning letters and enforcement, training, industry groups. 🔹 Bare feet in an ISO-classified suite?!?! 🔹 FDA’s Top Ten Issues cited in 483s have not really changed over 20+ years; rankings have shifted up or down, but it is still the same things 🔹 Similarly, DI (data integrity) is not a new concept. As Dr. Cavazonni said, “Get away from paper.” 🔹 “Reading an SOP is not training” – Alonza Cruse 🔹 “The battle is won and lost at the Supervisor level” – Kevin O’Donnell, (HPRA) 🔹 Have we forgotten about the patient? Have we forgotten who the patient is? Do we not realize we are The Patient? 🔹 “Cost of Quality” Why do we use this term? Why don’t we ever speak of the Cost of HR? The Cost of Supply Chain? of Technical Services? 🔹 Leadership sets the tone: it is the determiner of success. 🔹 Leadership is responsible for issues – whether they know it, or not. 🔹 Training, training, training. Real, intentional, training. Designing your org to be effective over the product life cycle should be your goal, not just for the next quarter’s results. Isn’t there a company out there that can help with this? 🔷 Eliquent – from thought to finish 🔷 Christie Bielinski; Karin Baer; Ileana Barreto-Pettit; Linda Evans O'connor;William (Al) Kentrup; Gerard (Jerry) Greco; Donald Ashley; Grace McNally ; Barbara Clendenen; Carmen C. Araujo; Elaine Shannon; Magaly Aham, MSc, RAC-US; Christina M. Mazzella; Domenic Veneziano; Sumaiya Reza; Zhenzhen Liu; Arlene Wolny; Arie Menachem; Saundrea Munroe; Jerome Chal; Maria McCaffrey; Cathy Burgess; Beth Weinman; Greg Levine ; Darrin Schellin; Brendan Carroll; Ben Wolf; Anthony Fanucci, PharmD, JD; Quality & Regulatory Network; Alonza Cruse; Michelle Toro, ASQ CQA, CSQP; Judy Zdanowicz; ELIQUENT Life Sciences; Eliquent Japan, Inc; Eli Shani; Ori Landau; Kimberly Garko; Jenna McCarthy

Where will EUCROF25 be held……one day to go until the big announcement……   Over our recent posts we’ve been sharing a teaser for where EUCROF25 will be held next February. Have you worked it out?    The big reveal will come soon, but here are a few hints in case you haven’t figured it out yet:   > Carlsberg Headquarters are located here > One of the city’s iconic landmarks is only 4.1ft (1.25m) tall > You will find one of the world’s oldest amusement parks here   If you want to find out where it is early, then head to the conference website at https://lnkd.in/e8bt2cqG Dr. Martine Dehlinger-Kremer, Simon Lee, Martin O'Kane, Sverre Bengtsson, Benedikt Van Nieuwenhove, Alexandre Malouvier, Antonio Torres, Nicole Bohrmann, Fiona Maini, Cristina Florescu Moraid, Alan Yeomans, Nira Garty   #EUCROF #clinicalresearch #clinicaltrials #clinicaloperations #gcp #bigpharma #dct #EUCROF25

Are you in the Life Sciences Eco-system and in the GTA? Here is an event to look into!

Check out these top #partnering tips from our partner Inpart and start arranging your meetings at #BIO2024. Fill out their annual partnering survey to receive your copy. #biotech #businessdevelopment #networking

Join this incredible group of experts as they dive into "Exploring a Successful Coexistence Between the Cannabis and Hemp Industries." This is a must-attend session for anyone looking to understand the evolving relationship between these two critical sectors.

The wait is nearly over! There's just under 1 week to go until the  3𝒓𝒅 𝑮𝑷𝑪𝑹𝒔-𝑻𝒂𝒓𝒈𝒆𝒕𝒆𝒅 𝑫𝒓𝒖𝒈 𝑫𝒊𝒔𝒄𝒐𝒗𝒆𝒓𝒚 𝑺𝒖𝒎𝒎𝒊𝒕 kicks off. But don't worry, there's still time to register and join your community of drug hunting peers for unfiltered access to leading expertise from Zoë Hughes, PhD, Yue Liu, Xavier Leroy, PhD, Steve Gardner, Stephan Schann, Seungil Han, Robin Löving, Peter McNamara, Oliver Hartley, Niklas Larsson, Michael Goguen, Laetitia Comps-Agrar, Jean-Philippe Fortin, Irina Tikhonova, Graeme Milligan, Faiz Ahmad Mohammed, Erik Hembre, Edward Van Wezel, Cheng Zhang, Callum Dickson, Benjamin Chen, Barbara Cipriani, Aurélien Rizk, Andreas Busch, Ajay Yekkirala, PhD, Adnan S.and more! So, if your in the race to develop first- or best-in-class small molecule or biologics for GPCRs or finally unlock orphan GPCRs, don't miss out on hearing the latest developments and innovations at the world’s only and most comprehensive industry dedicated GPCR forum. With only 6 days left to secure your seat, register hear: https://ter.li/r9tuwy